T. Alfaro (Coimbra, Portugal), M. Vasakova (Praha 4, Czech Republic), J. Morisset (Montréal (QC), Canada), D. Castillo Villegas (Barcelona, Spain)
Clinical Analysis of Pathologically Diagnosed Cryptogenic Organizing Pheumonia:A 14-year Retrospective Analysis of 176 COP Patients.
Y. Zhang (Shanghai, China), N. Li (Shanghai, China), H. Li (Shanghai, China), Y. Hu (Shanghai, China), Q. Li (Shanghai, China), Y. Zhou (Shanghai, China), L. Shen (Shanghai, China), F. Zhang (Shanghai, China), Y. Su (Shanghai, China), D. Weng (Shanghai, China)
|  |
Clinical characteristics of familial Idiopathic Pulmonary Fibrosis (f-IPF) at the University of Giessen Marburg Lung Center.
E. Krauss (Giessen, Germany), G. Von Gehrken (Giessen, Germany), S. Heinemann (Giessen, Germany), W. Seeger (Giessen, Germany), A. Guenther (Giessen, Germany)
|  |
Idiopathic interstitial pneumonias: Distinct Characteristics
R. Fessi (Tunis, Tunisia), B. Ourari (Tunis , Tunisia), J. Ben Amar (Tunis , Tunisia), H. Zaibi (Tunis , Tunisia), S. Azzabi (Tunis , Tunisia), M. Baccar (Tunis , Tunisia), H. Aouina (Tunis , Tunisia)
| |
TERT/TERC mutations in a Greek cohort of suspected genetic pulmonary fibrosis patients
E. Manali (Athens, Greece), C. Kannengiesser (Paris, France), L. Kolilekas (Athens, Greece), I. Korbila (Athens, Greece), G. Papadaki (Athens, Greece), M. Kallieri (Athens, Greece), P. Giouleka (Athens, Greece), A. Papaioannou (Athens, Greece), I. Tomos (Athens, Greece), E. Stagaki (Athens, Greece), A. Papaporfyriou (Athens, Greece), A. Karakatsani (Athens, Greece), S. Loukides (Athens, Greece), K. Kagouridis (Athens, Greece), V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), K. Antoniou (Heraklion, Greece), A. Trachalaki (Heraklion, Greece), A. Markopoulou (Thessaloniki, Greece), Z. Daniil (Larissa, Greece), E. Fouka (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece), A. Xyfteri (Messini Messinias, Greece), A. Gogali (Ioannina, Greece), A. Konstantinidis (Ioannina, Greece), P. Steiropoulos (Komotini, Greece), I. Papanikolaou (Corfu , Greece), C. Bazaka (Agrinio, Aetolia-Acarnania , Greece), A. Charitou (Ioannina , Greece), M. Maniati (Ioannina , Greece), P. Lyberopoulos (Athens, Greece), K. Vlami (Athens, Greece), T. Raptakis (Athens, Greece), P. Revy (Paris, France), M. Gaga (Athens , Greece), P. Dieude (Paris, France), N. Nathan (Paris, France), R. Borie (Paris, France), C. Boileau (Paris, France), D. Bouros (Athens, Greece), B. Crestani (Paris, France), S. Papiris (Athens, Greece), (Athens, Greece)
| |
Correlation between pulmonary function tests and HRCT indexes in Idiopathic Pulmonary Fibrosis (IPF) patients
S. Torrisi (Catania, Italy), S. Palmucci (Catania, Italy), R. Rosso (Catania, Italy), M. Schisano (Catania, Italy), M. Pavone (Catania, Italy), A. Vancheri (Catania, Italy), G. Sardo (Catania, Italy), R. Iudica (Catania, Italy), C. Vancheri (Catania, Italy)
| |
Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss
T. Watanabe (TOYOAKE, Japan), T. Minezawa (TOYOAKE, Japan), Y. Goto (TOYOAKE, Japan), T. Okamura (TOYOAKE, Japan), Y. Sakakibara (TOYOAKE, Japan), Y. Niwa (TOYOAKE, Japan), M. Hayashi (TOYOAKE, Japan), M. Hasegawa (TOYOAKE, Japan), K. Imaizumi (TOYOAKE, Japan)
| |
Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis
H. Ohkubo (Nagoya, Japan), K. Fukumitsu (Nagoya, Japan), S. Fukuda (Nagoya, Japan), Y. Kanemitsu (Nagoya, Japan), M. Takemura (Nagoya, Japan), K. Maeno (Nagoya, Japan), Y. Ito (Nagoya, Japan), A. Niimi (Nagoya, Japan)
| |
Telomere length in fibrotic groups of Interstitial Lung Diseases
I. Tomos (Athens, Greece), A. Karakatsani (Athens, Greece), E. Manali (Athens, Greece), . Kottaridi (Athens, Greece), . Spathis (Athens, Greece), . Korbila (Athens, Greece), . Kolilekas (Athens, Greece), . Kagouridis (Athens, Greece), . Foukas (Athens, Greece), . Papiris (Athens, Greece)
| |
Lymphocytes in bronchoalveolar lavage fluid might be useful for predicting the prognosis, even in the stable phase of nonspecific interstitial pneumonia
Y. Takeno (Yufu, Japan), K. Umeki (Yufu, Japan), K. Komiya (Yufu, Japan), Y. Usagawa (Yufu, Japan), M. Yamasue (Yufu, Japan), S. Nureki (Yufu, Japan), M. Ando (Yufu, Japan), K. Hiramatsu (Yufu, Japan), J. Kadota (Yufu, Japan)
| |
Evaluation of the 4-meter gait speed (4mGS) in patients with interstitial pneumonia: a prospective observational study.
R. Hirabayashi (Kobe, Japan), Y. Takahashi (Kobe, Japan), K. Wakata (Kobe, Japan), K. Nagata (Kobe, Japan), K. Hosoya (Kobe, Japan), H. Kawachi (Kobe, Japan), R. Mori (Kobe, Japan), M. Ito (Kobe, Japan), M. Kogo (Kobe, Japan), D. Fujimoto (Kobe, Japan), A. Nakagawa (Kobe, Japan), R. Tachikawa (Kobe, Japan), K. Otsuka (Kobe, Japan), K. Tomii (Kobe, Japan)
| |
Diagnostic contribution of EBUS in Interstitial Lung Desease (excluding Sarcoidosis)
W. Khamis (Bobigny, France), D. Basille (Amiens, France), J. Bernaudin (Bobigny, France), J. Morvan (Amiens, France), M. Soussan (Bobigny, France), M. Auquier (Amiens, France), K. Levand (Bobigny, France), P. Brillet (Bobigny, France), E. Magois (Amiens, France), C. Dayen (Saint-Quentin , France), Y. Douadi (Saint-Quentin , France), D. Valeyre (Bobigny, France), V. Jounieaux (Amiens, France), H. Nunes (Bobigny, France), O. Freynet (Bobigny, France)
| |
Histological patterns of resected lung after lung transplant in patients with interstitial lung diseases
T. Sa (Lisboa, Portugal), V. Caldeira (Lisboa, Portugal), S. Silva (Lisboa, Portugal), N. Caires (Lisboa, Portugal), R. Carvalho (Lisboa, Portugal), R. Coelho (Lisboa, Portugal), A. Borba (Lisboa, Portugal), E. Pinto (Lisboa, Portugal), P. Calvinho (Lisboa, Portugal), L. Semedo (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal), J. Fragata (Lisboa, Portugal)
| |
Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: a systematic review and meta-analysis
H. Kamiya (Perth, Australia), O. Panlaqui (Richmond, Australia)
| |
Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases
N. Eszes (Budapest, Hungary), P. Horváth (Budapest, Hungary), F. Klinger (Munich, Germany), Á. Tárnoki (Budapest, Hungary), D. Tárnoki (Budapest, Hungary), V. Müller (Budapest, Hungary), A. Bohács (Budapest, Hungary)
| |
Nailfold capillaroscopy findings in ILD patients: results from a single centre investigation.
F. Kühner (Lucern, Switzerland), O. Sander (Düsseldorf, Germany), E. Börner (Essen, Germany), T. Wessendorf (Essen, Germany), U. Costabel (Essen, Germany), F. Bonella (Essen, Germany)
| |
Impact of an interstitial lung diseases Nurse on the compliance to anti-fibrotic drugs in patients with Idiopathic Pulmonary Fibrosis.
O. Moran Mendoza (Kingston, Canada), S. Aldhaheri (Kingston, Canada), L. Mccarthy (Kingston, Canada)
| |
Antifibrotic choice in idiopathic pulmonary fibrosis
C. Hayton (Manchester, United Kingdom), H. Morris (Manchester, United Kingdom), T. Marshall (Manchester, United Kingdom), K. Zakis (Manchester, United Kingdom), T. Garfoot (Manchester, United Kingdom), P. Rivera Ortega (Manchester, United Kingdom), M. Greaves (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), N. Chaudhuri (Manchester, United Kingdom)
| |
Predictor factors of mortality in patients with idiopathic pulmonary fibrosis
A. Akçeli Sahin (Istanbul, Turkey), Z. Bingol (Istanbul, Turkey), Z. Kilicaslan (Istanbul, Turkey), T. Cagatay (Istanbul, Turkey), G. Okumus (Istanbul, Turkey)
| |
Composite Physiological Index as predictor of mortality by using IPF-GAP model
A. Gupta (ajmer, India), N. Gupta (ajmer, India), R. Dixit (ajmer, India)
| |